Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Gross Margin (2022 - 2026)

Cannabis Bioscience International Holdings filings provide 5 years of Gross Margin readings, the most recent being 72.82% for Q1 2026.

  • On a quarterly basis, Gross Margin rose 10273.0% to 72.82% in Q1 2026 year-over-year; TTM through Feb 2026 was 78.78%, a 801.0% decrease, with the full-year FY2025 number at 86.76%, up 509.0% from a year prior.
  • Gross Margin reached 72.82% in Q1 2026 per CBIH's latest filing, down from 80.29% in the prior quarter.
  • The five-year high for Gross Margin was 95.33% in Q3 2024, with the low at 29.9% in Q1 2025.
  • A 5-year average of 70.71% and a median of 78.31% in 2023 define the central range for Gross Margin.
  • Year-over-year, Gross Margin crashed -9747bps in 2025 and then soared 10273bps in 2026.
  • Year by year, Gross Margin stood at 91.41% in 2022, then decreased by -17bps to 76.33% in 2023, then increased by 17bps to 89.49% in 2024, then dropped by -10bps to 80.29% in 2025, then dropped by -9bps to 72.82% in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Gross Margin are 72.82% (Q1 2026), 80.29% (Q4 2025), and 66.35% (Q3 2025).